Alnylam Pharmaceuticals
ALNY
#902
Rank
$27.43 B
Marketcap
$205.52
Share price
0.02%
Change (1 day)
-48.85%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company